tiprankstipranks
Advertisement
Advertisement
Analyst Initiates Buy Rating on Caris, Highlighting Caris Detect Launch and Early Positive Economics
PremiumRatingsAnalyst Initiates Buy Rating on Caris, Highlighting Caris Detect Launch and Early Positive Economics
25d ago
Caris Life Sciences announces commercial launch of Caris Detect test
Premium
The Fly
Caris Life Sciences announces commercial launch of Caris Detect test
26d ago
Caris Life Sciences announces dual listing on NYSE Texas
Premium
The Fly
Caris Life Sciences announces dual listing on NYSE Texas
1M ago
Caris Life Sciences submits application to NYSDOH for Caris Assure testing
PremiumThe FlyCaris Life Sciences submits application to NYSDOH for Caris Assure testing
3M ago
Caris Life Sciences price target lowered to $22 from $28 at Baird
Premium
The Fly
Caris Life Sciences price target lowered to $22 from $28 at Baird
3M ago
Caris Life Sciences price target lowered to $32 from $38 at BTIG
Premium
The Fly
Caris Life Sciences price target lowered to $32 from $38 at BTIG
3M ago
Caris Life Sciences reports Q1 EPS 0c, consensus (2c)
PremiumThe FlyCaris Life Sciences reports Q1 EPS 0c, consensus (2c)
3M ago
Caris Life Sciences still sees 2026 revenue $1.0B-$1.02B, consensus $1.01B
Premium
The Fly
Caris Life Sciences still sees 2026 revenue $1.0B-$1.02B, consensus $1.01B
3M ago
Caris Life Sciences’ ChromoSeq receives MolDX approval
Premium
The Fly
Caris Life Sciences’ ChromoSeq receives MolDX approval
3M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―